Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study

RecruitingOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

December 1, 2025

Study Completion Date

December 31, 2025

Conditions
Helicobacter PyloriAtrophic GastritisIntestinal Metaplasia
Interventions
DIAGNOSTIC_TEST

Esophagogastroduodenoscopy

"To set up a prospective study and registry (HAR-P) for patients with H. pylori infection, atrophic gastritis or intestinal metaplasia to evaluate their clinical features and outcomes. The objectives include:~1. Assess the short- and long-term patient outcomes of H. pylori patients~2. Characterize factors involved in the progression or regression of pre-neoplastic lesions, namely atrophic gastritis and intestinal metaplasia~3. Gather information for a better understanding on the efficacy and role of surveillance~4. Potential for the development of new screening/surveillance strategies and tools for better risk stratification of patients~5. Establish a biobank for H. pylori, atrophic gastritis and intestinal metaplasia patients"

Trial Locations (2)

Unknown

RECRUITING

Prince of Wales Hospital, Hong Kong

RECRUITING

S.H. Ho Centre for Digestive Health, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER